Vitura Health Ltd (VIT) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.030x

Based on the latest financial reports, Vitura Health Ltd (VIT) has a cash flow conversion efficiency ratio of -0.030x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.37 Million ≈ $-968.70K USD) by net assets (AU$45.36 Million ≈ $32.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Vitura Health Ltd to measure how many days the company can operate on defensive assets alone.

Vitura Health Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Vitura Health Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vitura Health Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vitura Health Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Elicera Therapeutics AB
ST:ELIC
-0.156x
Inter-M Corporation
KQ:017250
0.026x
In8bio Inc
NASDAQ:INAB
-0.217x
Weizmann Limited
NSE:WEIZMANIND
0.281x
Southern Hemisphere Mining Ltd
AU:SUH
-1.457x
Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk PT
JK:JMAS
-0.165x
Jadi Imaging Holdings Bhd
KLSE:7223
0.001x
L&P Global Berhad
KLSE:0268
0.032x

Annual Cash Flow Conversion Efficiency for Vitura Health Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Vitura Health Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Vitura Health Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$47.60 Million
≈ $33.68 Million
AU$2.67 Million
≈ $1.89 Million
0.056x -69.21%
2024-06-30 AU$38.44 Million
≈ $27.20 Million
AU$7.00 Million
≈ $4.95 Million
0.182x -34.57%
2023-06-30 AU$34.90 Million
≈ $24.70 Million
AU$9.71 Million
≈ $6.87 Million
0.278x -46.29%
2022-06-30 AU$26.07 Million
≈ $18.45 Million
AU$13.50 Million
≈ $9.56 Million
0.518x +347.24%
2021-06-30 AU$9.22 Million
≈ $6.53 Million
AU$1.07 Million
≈ $755.67K
0.116x +131.96%
2020-06-30 AU$13.50 Million
≈ $9.55 Million
AU$-4.89 Million
≈ $-3.46 Million
-0.362x -210.73%
2019-06-30 AU$14.22 Million
≈ $10.06 Million
AU$-1.66 Million
≈ $-1.17 Million
-0.117x -103.10%
2018-06-30 AU$67.47K
≈ $47.74K
AU$253.35K
≈ $179.26K
3.755x +307.75%
2017-06-30 AU$-22.22K
≈ $-15.72K
AU$-20.46K
≈ $-14.48K
0.921x --

About Vitura Health Ltd

AU:VIT Australia Drug Manufacturers - Specialty & Generic
Market Cap
$14.07 Million
AU$19.88 Million AUD
Market Cap Rank
#26180 Global
#1197 in Australia
Share Price
AU$0.03
Change (1 day)
+0.00%
52-Week Range
AU$0.03 - AU$0.07
All Time High
AU$0.96
About

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual h… Read more